Navigation Links
Saladax Biomedical Announces Addition to Leadership Team
Date:7/22/2013

BETHLEHEM, Pa., July 22, 2013 /PRNewswire-iReach/ -- Saladax Biomedical, Inc., a privately held company developing novel diagnostic tests with the goals of improving health and positively impacting the economics of care, today announced the hiring of John McAuliffe as Vice President of Companion Diagnostics Business Development. Mr. McAuliffe has over 20 years' experience in healthcare serving in roles including drug development, sales, marketing and business development. Prior to joining Saladax, Mr. McAuliffe contributed to the success of Athena Diagnostics during his 13 year tenure by serving in various roles up to and including Director of Business Development, Neurology where he was responsible for management of biomedical research as well as the identification, evaluation and launch of over 100 protein and molecular diagnostic assays, which led to acquisition by Quest Diagnostics from Thermo Fisher Scientific in 2011. Mr. McAuliffe is a member of the American Academy of Neurology, the American Society of Human Genetics, holds a Bachelor Degree of Science, Pharmacology, from the University of California Santa Barbara and has contributed to various peer reviewed scientific publications.

"Mr. McAuliffe is an excellent sales and business development professional with an undergraduate degree in pharmacology, background in pharmaceutical sales, experience in Companion Diagnostic deals, and is knowledgeable and published in the Alzheimer's space. His focus will primarily be to develop and manage business collaborations on the Companion Diagnostics side of our business." said Kevin Harter, President and CEO.

About Saladax Biomedical, Inc.

Saladax Biomedical is a leader in the development and deployment of high quality diagnostic services and products, delivering actionable data to help physicians to select and optimize the use of current and new pharmaceutical products, with the goals of improving health and positively impacting the economics of care. Saladax also serves as a valuable collaborator for pharmaceutical and biotechnology companies in the development of companion diagnostics (CDx), addressing multiple risks and challenges encountered in drug development.

​www.Saladax.com

Media Contact: Lorraine Damico, MBA, Saladax Biomedical Inc., 484-547-0529, ldamico@saladax.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Saladax Biomedical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
2. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
3. Saladax Biomedical, Inc. Announces the Formation of a CLIA Laboratory As Part of the Companys Commercialization Strategy
4. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
5. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
6. Live Press Briefing on Findings of Biomedical Industry CEO Survey
7. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
8. ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd.
9. Minority Biomedical Entrepreneurship Conference
10. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
11. Fluke Biomedical training center goes global: adds multi-language support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... and SAN FRANCISCO , ... privately-held regenerative medicine company, and Beyond Type 1, a ... type 1 diabetes, today announced a grant from Beyond ... functional cure for type 1 and other insulin-requiring diabetes.  ... has been developing innovative stem cell-derived cell replacement therapies ...
(Date:2/22/2017)... Feb. 22, 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a ... of innovative biopharmaceutical products for companion animals, will host a ... a.m. ET to discuss financial results from the fourth quarter ... Interested participants and investors may access the audio webcast ... ...
(Date:2/22/2017)... ... ... Park Systems , a leader in Atomic Force Microscopy (AFM) since ... attendees and Park customers on Feb. 27, 2017 from 12-2pm at Morton’s The Steakhouse ... The luncheon will feature a talk on Automated AFM for Small-Scale and Large-Scale Surface ...
(Date:2/22/2017)... Scientists propose in Nature blocking ... Gaucher and maybe other lysosomal storage diseases as a ... current therapies. An international research team led ... also included investigators from the University of Lübeck in ... 22. The study was conducted in mouse models of ...
Breaking Biology Technology:
(Date:2/8/2017)... 7, 2017 Report Highlights The ... from $8.3 billion in 2016 at a compound annual ... Report Includes - An overview of the global ... with data from 2015 and 2016, and projections of ... of the market on the basis of product type, ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute announced ... Larry Schlesinger as the Institute,s new President and ... effective May 31, 2017. He is currently the Chair of ... the Center for Microbial Interface Biology at Ohio State University. ... the new President and CEO of Texas Biomed," said Dr. ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, ... a new report, Sensors for Robotics: Technologies, Markets and Forecasts ... ... Revenues ... "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force ...
Breaking Biology News(10 mins):